Call for Applications: Target Identification in Lupus
Letter of intent due date: July 10, 2014 Application due date: August 25, 2014 The Alliance for Lupus Research (ALR) is pleased to announce that the applications for the ALR’s Target Identification in Lupus (TIL) grants are now available online. The guidelines and application are also available through the Altum proposalCENTRAL website at https://proposalcentral.altum.com. Funding for the TIL award will be made for up to $200,000 per year (for a maximum of three years - total amount up to $600,000) including indirect costs. Funding for the third year is based on the successful submission of a n...
Source: ScanGrants feed - June 5, 2014 Category: Research Authors: Alliance for Lupus Research Source Type: funding
Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)
Funding Opportunity Number: PAR-14-242 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.27393.39393.396Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3)...
Source: Grants.gov - June 3, 2014 Category: Research Tags: Education Health Source Type: funding
Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)
Funding Opportunity PAR-14-242 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages innovative multidisciplinary research projects that will advance our mechanistic understanding of microflora influences on Gastro-Intestinal (GI) carcinogenesis. Recent advances in our knowledge of GI microflora composition and function have generated a flood of new information, technologies, and capabilities that may for the first time allow mechanistic investigations of very complex, networked host/microbiome interactions on a systems wide scale.This FOA encourages investigators to ingr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 3, 2014 Category: Research Source Type: funding
Development of Sample Sparing Assays for Monitoring Immune Responses (U24)
Funding Opportunity Number: RFA-AI-14-027 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.24293.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a...
Source: Grants.gov - June 3, 2014 Category: Research Tags: Health Source Type: funding
Development of Sample Sparing Assays for Monitoring Immune Responses (U24)
Funding Opportunity RFA-AI-14-027 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to accelerate the development and validation of sample sparing assays that can be applied for studying the human immune system in health and disease.Development of sample sparing assays will lead to maximum use of the sampled material by significant reduction of sample volumes/amounts required or by simultaneous multi-parameter assessments of immune function.By expanding the spectrum of parameters that can be measured on small samples derived from human subjects, assays develope...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 2, 2014 Category: Research Source Type: funding
